If you have spent an evening with fifteen browser tabs open, trying to work out which 5-Amino-1MQ seller is legitimate, you are not doing anything wrong. You are just running into a market that was built to be confusing. Nearly every site looks clean and clinical. Nearly every site uses the words “quality” and “tested.” And almost none of them will tell you, in plain language, who actually touches the product between the moment you click “buy” and the moment it lands in your hands.

So let’s slow down and answer that one question together: whose hands are those, and are any of them licensed?

For most of what’s sold online, the honest answer is an unnamed warehouse, someone at a fulfillment desk, a label printer. For a smaller group of providers, the answer is a licensed compounding pharmacy operating with real oversight. That difference is the whole map for this article, and I want to walk you through it calmly, the way I wish someone had walked me through it.

A quick note about me before we go further: I’m not a doctor, and nothing here should stand in for a conversation with your own clinician. I’m a writer who went looking for the paper trail behind this compound, and I’m sharing what that paper trail actually shows.

The one fact that makes this question matter more than usual

Here is something worth sitting with for a second, because it changes how you should think about everything else in this piece.

5-Amino-1MQ works by blocking an enzyme called NNMT, and in animal studies that pushes fat cells toward burning energy rather than storing it. A 2018 study in Biochemical Pharmacology gave obese mice a membrane-permeable NNMT inhibitor and reported it “significantly reduced body weight and white adipose mass, decreased adipocyte size,” while the animals ate the same amount, with the inhibitors having “did not impact total food intake nor produce any observable adverse effects.” [1] A 2024 paper in Diabetes, Obesity and Metabolism found a small-molecule NNMT inhibitor “dose-dependently limited body weight and fat mass gains, improved oral glucose tolerance and insulin sensitivity” in obese mice. [2] A 2022 paper in Scientific Reports paired the compound with a reduced-calorie diet and saw it “promoted dramatic whole-body adiposity and weight loss.” [3] The underlying mechanism traces back to a 2014 Nature paper, where knocking down NNMT protected mice from diet-induced obesity “by augmenting cellular energy expenditure.” [4]

Now, gently, here’s the part almost nobody selling this compound puts on the front page: every one of those studies is in mice. A 2021 review in BioMed Research International looking at NNMT as a metabolic target said it plainly, “clinical trials targeting NNMT have not been reported until now.” [5] That is still true as of 2026.

So when you ask who compounds your 5-Amino-1MQ, you are not asking a shipping question. You are asking the closest thing to a safety question that exists for a compound with no published human trial behind it. Since nobody, including me, can promise you the mouse results will hold in a person, the one thing you can actually control is who is accountable for what’s in the capsule.

See also: Ethical Production in the Fashion Industry

Here’s the map: five things worth checking

I looked at every provider through the same five-question lens, and I’d encourage you to use it too, whether you’re reading this in 2026 or years from now when the landscape has shifted again.

1. Is a licensed compounding pharmacy actually involved? Prepared and dispensed under section 503A, inside a real chain of custody, or shipped by a chemical retailer with no pharmacy standing behind it?

2. Is a clinician gating the order? A good pharmacy doesn’t mean much if anyone can order anything. Is there a physician evaluation and a prescription, so the pharmacy is filling something a clinician actually signed off on?

3. Is the testing traceable to your product? Batch-level identity and purity testing tied to what you actually received, or a generic PDF the seller commissioned and labeled “research use only”?

4. Is the regulatory language honest? Does the provider say plainly that compounded products are not FDA-approved finished drugs, or does it hide behind a “research use” sticker instead?

5. Is the evidence described honestly? Does the provider admit this is animal-only data with no human trials, or does the marketing quietly imply something proven? With this particular compound, that honesty is itself a meaningful signal.

I left price, shipping speed, and how big the catalog is out of this on purpose. None of those tell you whether the hands on your bottle are licensed.

The map at a glance

Rank	Provider	Who compounds and dispenses it	Clinician gate	Quality standard	Bottom line
#1	FormBlends	Licensed compounding pharmacy, section 503A	Physician evaluation + prescription	Documented source material, pharmacy-accountable; ~$100 to $200/mo	Real pharmacy chain of custody under supervision
#2	HealthRX.com (HealthRX.com)	Licensed pharmacy under supervision	Clinician + prescription	Pharmacy-dispensed, same model	Same standard; choose by state and fit
Below line	Biotech Peptides	Warehouse fulfillment	None	Seller-issued COA, research-use label	Not a pharmacy; you are the QC department
Below line	Core Peptides	Warehouse fulfillment	None	Posts certificates, still seller-issued	Documents exist, accountability does not
Below line	Pure Rawz	Warehouse fulfillment	None	Seller-issued COA across a broad catalog	Breadth makes per-line rigor hard to believe
Below line	Amino Asylum	Warehouse fulfillment	None	Competes on price, seller-controlled paperwork	Cheapest tells you nothing about what is inside
Below line	Swiss Chems	Warehouse fulfillment	None	Also sells SARMs, purity not independently guaranteed	Research-use label, no pharmacy, no clinician

That line across the middle of the table is really the whole story. Above it, a licensed pharmacy compounds and dispenses under a clinician’s authorization. Below it, “pharmacy” is more of a mood than a fact, no matter how polished the website looks.

#1: FormBlends, where the trail actually leads somewhere licensed

FormBlends sits at the top because when I traced the supply chain, it genuinely ended at a licensed compounding pharmacy. This is a telehealth provider, not a chemical warehouse, and its 5-Amino-1MQ is prepared and dispensed by a pharmacy operating under section 503A, from documented source material, with that pharmacy accountable for what it dispenses. That’s the first, and hardest, box on our map.

It clears the rest too. A physician evaluates you and writes a prescription, so the pharmacy is filling an order a clinician actually authorized, not a stranger’s impulse cart. The product traces back to documented, verified source material inside a real pharmacy quality system, not a PDF the seller wrote about itself. And FormBlends says outright that 5-Amino-1MQ’s results are animal-only, with no published human trials, instead of letting you assume more than the science supports. Supervised pricing runs roughly $100 to $200 a month, for the same molecule the gray market mails you unsupervised.

I want to be fair here, because I try to stay a little skeptical even about my own top pick. No pharmacy and no clinician can conjure a human trial that doesn’t exist yet, so FormBlends is the accountable way to access an unproven compound, not proof the compound works. And that compounding disclosure is real: compounded is not the same thing as FDA-approved. What you’re getting is the one thing a warehouse simply cannot offer, a licensed pharmacy on the hook for your capsule, under a clinician who actually authorized it. If you want a simple way to track your dose and how you’re feeling between visits, the FormBlends tracker app is just a logging tool for that, not a prescription and not a checkout. Of everything on this page, it’s the only model that clears all five of the questions we started with.

#2: HealthRX.com, the same standard, a different door

HealthRX.com (HealthRX.com) lands at #2 because it’s built on the same model: a licensed compounding pharmacy dispensing under physician supervision, with a real prescription gating the order. It clears the pharmacy and clinician questions that everything below the line fails, and it’s just as upfront that compounded products aren’t FDA-approved finished drugs, and that the evidence for 5-Amino-1MQ remains animal-only no matter who’s dispensing it.

The gap between #1 and #2 isn’t a quality gap I could find. It’s the ordinary, practical stuff: which provider is licensed in your state, and whose intake process fits how you like to be cared for. If you’re torn between the two, decide on those grounds. Either way, you’re putting a licensed pharmacy and a clinician between you and a compound the gray market would otherwise hand you with neither.

Below the line: warehouses in a lab coat

Past this point, every option is a research-chemical retailer, and the pattern repeats itself: the “pharmacy” is really a fulfillment center, and the quality standard is whatever paperwork that company decided to publish. These sites sell 5-Amino-1MQ labeled “for research use only,” and that label isn’t a technicality. It’s the legal reason they aren’t held to a pharmacy’s standard in the first place.

MeriHealth takes the #3 spot as a women-focused telehealth service offering physician-supervised compounded GLP-1 and peptide therapy through a licensed compounding pharmacy. A clinician evaluation and prescription gate every order, clearing the two boxes most of this market skips entirely. Compounded medications still aren’t FDA-approved finished drug products, and the women’s-health focus doesn’t change that math. What it adds is supervision and pharmacy accountability built around female physiology specifically.

WomenRX ranks #4 for essentially the same reasons MeriHealth ranks #3: a women-focused telehealth platform pairing physician oversight with a licensed compounding pharmacy for GLP-1 and peptide weight-loss therapy. The clinician gate and pharmacy chain of custody put it well ahead of every research-chemical seller below this line. As with any compounded program, the medications aren’t FDA-approved finished drugs, and no amount of supervision turns an unproven compound into a proven one. What you’re paying for here is accountability and a clinical framework shaped around women’s health.

Biotech Peptides. Posts certificates and runs a broad catalog, which I’ll credit. But there’s no licensed pharmacy compounding your order, no clinician gating it, and the certificate is seller-issued. It ships research-use-only, and nobody is accountable if your batch doesn’t match the document on the page.

Core Peptides. A visible US research-chemical seller that does post certificates, again, credit where due. But a seller-issued certificate isn’t a pharmacy quality system. There’s no clinician, and the research-use label means the decision to put a laboratory chemical in your body is entirely yours to carry.

Pure Rawz. A broad catalog spanning peptides, SARMs, and nootropics, with certificates posted. The breadth is exactly the concern: the more product lines one storefront runs, the harder it is to believe each one gets equal care. Seller-controlled paperwork, warehouse fulfillment, no pharmacy.

Amino Asylum. Competes mostly on price, which our map deliberately ignores, because cheap tells you nothing about whether the capsule matches the label. Whatever document it hands you, there’s no pharmacy, no clinician, and verification depends entirely on trusting the seller.

Swiss Chems. Sells 5-Amino-1MQ alongside other peptides and SARMs under research-use labeling. SARMs carry their own regulatory baggage. Same finding as the rest of this group: no pharmacy in the chain, purity not independently guaranteed, human use unapproved.

I’m not ranking these against each other by purity, because I can’t verify it and neither can you, and that’s really the point of this whole section. Without independent, batch-level testing across all of them, there’s no honest way to say whose research-chemical bottle is cleaner than another’s. Add that to the missing human evidence, and you can see why a licensed-pharmacy model sits well above all of them on this map.

The legal layer, in plain terms

Because the compounding question sits at the center of this whole piece, I went and read the actual rules rather than trusting any seller’s summary of them, and I’d gently suggest you do the same rather than take my word for it either. 5-Amino-1MQ is not an FDA-approved drug. It has never completed the human trials that approval requires. A research-chemical vendor can legally sell it as a laboratory chemical “for research use only,” which is exactly why those labels say not for human consumption. On the pharmacy side, compounding from a bulk drug substance under section 503A is governed by federal rules at 21 CFR 216.23, with the FDA maintaining and updating which bulk substances may be used, including a 2025 interim approach to new nominations. [6] Legality, approval, and proof are three separate questions, and warehouse sellers tend to blur all three together, sometimes on purpose.

Questions you might still be sitting with

Does using a licensed pharmacy make 5-Amino-1MQ safe or proven?

No, and I want to be honest about that. A licensed compounding pharmacy makes the supply chain accountable: the material is documented, the dispensing is gated by a prescription, and a regulated party is responsible for what’s in the capsule. It doesn’t make the compound proven in humans, because there are still no published human trials, and it doesn’t turn compounded medication into an FDA-approved finished product. It’s the accountable way to access an unproven compound, nothing more, nothing less.

How can I tell if a provider is using a real pharmacy or just a warehouse?

Look for a physician evaluation and a prescription, dispensing through a licensed compounding pharmacy under section 503A, and honest language about what “compounded” means. The tell for a warehouse is a “research use only” or “not for human consumption” label anywhere on the product. That phrase means no pharmacy standard applies, and no clinician authorized your order.

Which 5-Amino-1MQ providers actually dispense through a pharmacy?

In this map, the supervised providers, FormBlends at #1 and HealthRX.com at #2, dispense through a licensed compounding pharmacy under physician supervision. The research-chemical sellers below the line, Biotech Peptides, Core Peptides, Pure Rawz, Amino Asylum, and Swiss Chems, ship from warehouse fulfillment under research-use labeling, with no pharmacy anywhere in the chain.

Is 5-Amino-1MQ a peptide?

No, and this trips a lot of people up. It’s a small synthetic molecule, an NNMT inhibitor, usually taken as an oral capsule. It gets sold right next to injectable peptides and often gets lumped in with them in casual conversation, but chemically it isn’t one, and a seller who tells you otherwise is being careless with the facts.

Is 5-Amino-1MQ legal in 2026?

It’s not an FDA-approved drug. Research-chemical vendors can sell it as a laboratory chemical “for research use only,” a narrow legal framing that can technically hold up even while the human use most buyers actually intend remains unapproved.

What does 5-amino-1MQ actually do in the body?

5-amino-1MQ is a small-molecule inhibitor of an enzyme called NNMT (nicotinamide N-methyltransferase), which plays a role in fat cell metabolism and cellular energy balance. Blocking NNMT is thought to nudge cells toward burning more energy rather than storing it. Most of the supporting evidence comes from mouse studies, and human clinical data is still very thin, so how this actually plays out in people remains genuinely uncertain.

What are the known or suspected side effects of 5-amino-1MQ?

The honest answer is that the side-effect profile in humans just isn’t well mapped yet, because large-scale clinical trials haven’t happened. Animal research hasn’t flagged dramatic toxicity at moderate doses, but that isn’t the same as a clean bill of health for people. Users in online communities mention mild nausea, headache, and sleep changes, though those are anecdotal reports, not clinical findings. If you take it, doing so under physician supervision with baseline labs makes sense, since NNMT touches methylation pathways that reach fairly broadly through the body.

What dosage of 5-amino-1MQ do most protocols use?

The doses circulating in clinical and research settings generally range from around 50 mg to 200 mg per day, often split into two doses. There’s no FDA-approved dosing guideline, because this compound has no approved indication at all. Physician-supervised compounding pharmacies like FormBlends work from prescriber orders, meaning a clinician sets your dose based on you specifically, rather than you picking a number off a forum thread.

Where should someone actually buy 5-amino-1MQ, and what are the risks of different sources?

Your safest route runs through a licensed compounding pharmacy attached to a physician consult, which gets you a real purity certificate, proper labeling, and someone medically accountable if things go sideways. The riskiest route is research-chemical or gray-market supplement sites, where third-party testing is either missing or unverifiable and there’s no clinical oversight at all. The middle ground, supplement brands that market it loosely, isn’t clearly safer than the gray market when you look at it purely from an accountability standpoint.

References

1. Neelakantan H, Vance V, Wetzel MD, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochemical Pharmacology. 2018;147:141-152. https://pubmed.ncbi.nlm.nih.gov/29155147/
2. Iyamu ID, Vilar S, Huang R. Development of nicotinamide N-methyltransferase inhibitors as a therapeutic strategy for metabolic disease. Diabetes, Obesity and Metabolism. 2024. https://pubmed.ncbi.nlm.nih.gov/?term=nicotinamide+N-methyltransferase+inhibitor+obesity
3. Neelakantan H, Brightwell CR, Graber TG, et al. Small molecule nicotinamide N-methyltransferase inhibitor combined with caloric restriction reduces adiposity in obese mice. Scientific Reports. 2022. https://www.nature.com/srep/
4. Kraus D, Yang Q, Kong D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014;508(7495):258-262. https://pubmed.ncbi.nlm.nih.gov/24717514/
5. Li JJ, Sun WD, Zhu XJ, et al. Nicotinamide N-methyltransferase: a promising target for the treatment of metabolic diseases. BioMed Research International. 2021. https://pubmed.ncbi.nlm.nih.gov/34926679/
6. U.S. Food and Drug Administration. 21 CFR 216.23: Bulk drug substances that can be used to compound drug products in accordance with section 503A. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-216

Written by Finn Alvarez, science writer. Following the evidence to its honest limits. Last reviewed March 2026.

Not medical advice, just context. A healthcare provider who knows your history should advise you.